|
Neoplasia
Citations 361-370 of 4217 total displayed.
|
Past content
(since Jan 1997):
|
Wogonin preferentially kills malignant lymphocytes and suppresses T-cell tumor growth by inducing PLC 1- and Ca2+-dependent apoptosis
- Sven Baumann, Stefanie C. Fas, Marco Giaisi, Wolfgang W. Müller, Anette Merling, Karsten Gülow, Lutz Edler, Peter H. Krammer, and Min Li-Weber
Blood 2008; 111: 2354-2363.
[Abstract]
[Full text]
[PDF]
Bortezomib induces DNA hypomethylation and silenced gene transcription by interfering with Sp1/NF- B–dependent DNA methyltransferase activity in acute myeloid leukemia
- Shujun Liu, Zhongfa Liu, Zhiliang Xie, Jiuxia Pang, Jianhua Yu, Esther Lehmann, Lenguyen Huynh, Tamara Vukosavljevic, Mitsui Takeki, Rebecca B. Klisovic, Robert A. Baiocchi, William Blum, Pierluigi Porcu, Ramiro Garzon, John C. Byrd, Danilo Perrotti, Michael A. Caligiuri, Kenneth K. Chan, Lai-Chu Wu, and Guido Marcucci
Blood 2008; 111: 2364-2373.
[Abstract]
[Full text]
[PDF]
DNA methylation-independent loss of RARA gene expression in acute myeloid leukemia
- Annegret Glasow, Angela Barrett, Kevin Petrie, Rajeev Gupta, Manuel Boix-Chornet, Da-Cheng Zhou, David Grimwade, Robert Gallagher, Marieke von Lindern, Samuel Waxman, Tariq Enver, Guido Hildebrandt, and Arthur Zelent
Blood 2008; 111: 2374-2377.
[Abstract]
[Full text]
[PDF]
In vivo kinetics of kinase domain mutations in CML patients treated with dasatinib after failing imatinib
- Jamshid S. Khorashad, Dragana Milojkovic, Puja Mehta, Mona Anand, Sara Ghorashian, Alistair G. Reid, Valeria De Melo, Anna Babb, Hugues de Lavallade, Eduardo Olavarria, David Marin, John M. Goldman, Jane F. Apperley, and Jaspal S. Kaeda
Blood 2008; 111: 2378-2381.
[Abstract]
[Full text]
[PDF]
Induction of hypomethylation and molecular response after decitabine therapy in patients with chronic myelomonocytic leukemia
- Yasuhiro Oki, Jaroslav Jelinek, Lanlan Shen, Hagop M. Kantarjian, and Jean-Pierre J. Issa
Blood 2008; 111: 2382-2384.
[Abstract]
[Full text]
[PDF]
Ki-67 predicts outcome in advanced-stage mantle cell lymphoma patients treated with anti-CD20 immunochemotherapy: results from randomized trials of the European MCL Network and the German Low Grade Lymphoma Study Group
- Olaf Determann, Eva Hoster, German Ott, Heinz Wolfram Bernd, Christoph Loddenkemper, Martin Leo Hansmann, Thomas E. F. Barth, Michael Unterhalt, Wolfgang Hiddemann, Martin Dreyling, and Wolfram Klapper, for the European Mantle Cell Lymphoma Network and the German Low Grade Lymphoma Study Group
Blood 2008; 111: 2385-2387.
[Abstract]
[Full text]
[PDF]
Changes in the expression of telomere maintenance genes suggest global telomere dysfunction in B-chronic lymphocytic leukemia
- Delphine Poncet, Aurélie Belleville, Claire t'Kint de Roodenbeke, Aude Roborel de Climens, Elsa Ben Simon, Hélène Merle-Beral, Evelyne Callet-Bauchu, Gilles Salles, Laure Sabatier, Jozo Delic, and Eric Gilson
Blood 2008; 111: 2388-2391.
[Abstract]
[Full text]
[PDF]
Sexual function changes during the 5 years after high-dose treatment and hematopoietic cell transplantation for malignancy, with case-matched controls at 5 years
- Karen L. Syrjala, Brenda F. Kurland, Janet R. Abrams, Jean E. Sanders, and Julia R. Heiman
Blood 2008; 111: 989-996.
[Abstract]
[Full text]
[PDF]
Platelet-associated PF-4 as a biomarker of early tumor growth
- David Cervi, Tai-Tung Yip, Nandita Bhattacharya, Vladimir N. Podust, Jon Peterson, Abdo Abou-Slaybi, George N. Naumov, Elise Bender, Nava Almog, Joseph E. Italiano, Jr, Judah Folkman, and Giannoula L. Klement
Blood 2008; 111: 1201-1207.
[Abstract]
[Full text]
[PDF]
Bortezomib down-regulates the cell-surface expression of HLA class I and enhances natural killer cell–mediated lysis of myeloma
- Jumei Shi, Guido J. Tricot, Tarun K. Garg, Priyangi A. Malaviarachchi, Susann M. Szmania, Rachel E. Kellum, Brian Storrie, Arend Mulder, John D. Shaughnessy, Jr, Bart Barlogie, and Frits van Rhee
Blood 2008; 111: 1309-1317.
[Abstract]
[Full text]
[PDF]
|
|
